DAY THREE: 08 JULYAdvanced Models & Immunoassays
Benefit from case studies on preclinical models of safety & efficacy, including 3D, in-vivo and in-vitro models. Further talks look at assay development
Agenda at a Glance
Stream 2: Assay Development & Translational Strategies
- Assay development, including pharmacodynamic assays
- Preclinical efficacy and assay development
- Approaches to preclinical combination therapy design
- Alternative screening strategies
Day One Key Speakers include

SpeakerName
Company

SpeakerName
Company

SpeakerName
Company

SpeakerName
Company

SpeakerName
Company

SpeakerName
Company